Taking a rational approach in the treatment of avian mycobacteriosis

Vet Clin North Am Exot Anim Pract. 2012 Jan;15(1):57-70, vi. doi: 10.1016/j.cvex.2011.12.001.

Abstract

Treatment for avian mycobacteriosis is still in its infancy and based on extrapolations from human medicine. The optimum drug choice, dose, or length of treatment has yet to be determined for most exotic animal species. Treatment should include multiple drugs for extended periods of time with appropriate monitoring of both drug levels and overall animal health. Risk to owners and handlers needs to be minimized through appropriate identification of the species of mycobacteri causing disease. More research is necessary on the pharmacokinetics of these drugs in other animal species and antibiotic resistance. Currently, euthanasia remains the most common action in the face of active mycobacteriosis.

Publication types

  • Review

MeSH terms

  • Animals
  • Animals, Domestic
  • Animals, Wild
  • Animals, Zoo
  • Anti-Bacterial Agents / pharmacokinetics
  • Anti-Bacterial Agents / therapeutic use*
  • Birds
  • Dose-Response Relationship, Drug
  • Drug Resistance, Bacterial
  • Drug Therapy, Combination / veterinary
  • Euthanasia, Animal
  • Humans
  • Mycobacterium avium / classification
  • Mycobacterium avium / drug effects*
  • Mycobacterium avium / isolation & purification
  • Species Specificity
  • Treatment Outcome
  • Tuberculosis, Avian / drug therapy*
  • Tuberculosis, Avian / metabolism

Substances

  • Anti-Bacterial Agents